{"organizations": [], "uuid": "3a48e6607091ad3b81cce6d99e3bfbee6440bc62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-arcturus-therapeutics-comments-on/brief-arcturus-therapeutics-comments-on-amended-13d-filing-idUSFWN1Q60QI", "country": "US", "domain_rank": 408, "title": "BRIEF-Arcturus Therapeutics Comments On Amended 13D Filing", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-16T15:24:00.000+02:00", "replies_count": 0, "uuid": "3a48e6607091ad3b81cce6d99e3bfbee6440bc62"}, "author": "", "url": "https://www.reuters.com/article/brief-arcturus-therapeutics-comments-on/brief-arcturus-therapeutics-comments-on-amended-13d-filing-idUSFWN1Q60QI", "ord_in_thread": 0, "title": "BRIEF-Arcturus Therapeutics Comments On Amended 13D Filing", "locations": [], "entities": {"persons": [{"name": "joseph e. payne", "sentiment": "none"}, {"name": "payne", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "arcturus therapeutics ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 25 PM / Updated 9 minutes ago BRIEF-Arcturus Therapeutics Comments On Amended 13D Filing Reuters Staff Feb 16 (Reuters) - Arcturus Therapeutics Ltd: * ARCTURUS THERAPEUTICS COMMENTS ON AMENDED 13D FILING * ARCTURUS THERAPEUTICS LTD - COMMENTED ON AMENDED 13D FILING BY JOSEPH E. PAYNE * ARCTURUS THERAPEUTICS - IN AMENDED FILING, PAYNE PROPOSED TO NOMINATE 4 DIRECTOR CANDIDATES AND REQUESTED TO CONVENE EXTRAORDINARY GENERAL MEETING * ARCTURUS THERAPEUTICS LTD - ARCTURUS BOARD HAS INITIATED A PROCESS TO MEET WITH PROPOSED NOMINEES BY PAYNE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-16T15:24:00.000+02:00", "crawled": "2018-02-16T15:38:45.037+02:00", "highlightTitle": ""}